Conversely, an increased eosinophil count (p = 0.003) and percentage of CD4+ T cells (p = 0.01) were linked to a higher risk of cognitive impairment among patients in stage 3, although these associations were not statistically significant in stages 1 or 2. The gene discussed is CD4; the disease is Cognitive impairment.